EUCTR2008-006989-28-FI进行中（未招募）不适用
EXTENDED ANGIOCOMBAntiangiogenetic therapy for pediatric malignancies with no conventional treatment modalities left
HUCH, Hospital for Children and Adolescents0 个研究点开始时间: 2008年11月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Pediatric malignancies with no conventional treatment modalities left
- •Age 1-18 year
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 20
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Decline in consciousness, inability to swallow, need of opioids for pain
研究者
相似试验
进行中（未招募）
不适用
ANGIOCOMBAntiangiogenetic therapy for pediatric patients with brain stem tumors - AngiocombBrain sten tumorEUCTR2005-004850-28-FIHospital for Children and Adolescents
已完成
1 期
Angiogenesis augmentation therapy for indirect revascularization of moyamoya disease using G-CSFJPRN-jRCTs071220048Morioka Motohiro5
进行中（未招募）
不适用
Antiangiogenetic therapy for pediatric patients with inoperable benign tumorsEUCTR2008-006992-57-FIsanna kivivuori
尚未招募
不适用
Sonidegib (Odomzo) neo-adjuvant therapy for participants with Gorlin syndrome – A pilot studyGorlin SyndromeCancer - Other cancer typesSkin - Other skin conditionsHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersACTRN12620001200976Samson Clinical Pty Ltd6
尚未招募
Unknown
Adjuvant therapy in pathological stage IA2-IIA EGFR-mutated NSCLC: a multicenter prospective observational study (WJOG17123L)Completely resected pathological stage IA2-IIA EGFR-mutated NSCLCJPRN-UMIN000053514West Japan Oncology Group800